ABOUT CHDR
The Centre for Human Drug Research (CHDR) is an independent, full-service contract research organisation (CRO) that specialises in cutting-edge, early phase clinical drug research in both healthy volunteers and small patient cohorts, across a wide range of therapeutic areas. CHDR develops and uses state-of-the-art methods and research tools to collect as much information as possible about candidate drugs in the early phases of clinical development, helping sponsors make informed decisions regarding the further development of their product. The company serves as a ‘one-stop-shop’, offering end-to-end CRO solutions for early phase programs. In addition, CHDR operates a purpose-built, state-of-the-art phase 1 unit with 54 beds, as well as a hospital-based unit consisting of 8 beds.
FEATURED CONTENT
-
![GettyImages-1471734234-derm-dermatology-skin]( "Blueprint For Early Phase Clinical Pharmacology Studies In Dermatology")
Explore the landscape of dermatological drug development through a comprehensive framework for rational early-phase dermatological trials, centered around five foundational pillars.
-
![GettyImages-2081140990-phone-cellphone-hand]( "A Smartphone Based Biomarker For The Estimation Of Unipolar Depression Severity")
The study investigates the potential of using smartphones and wearables to create objective biomarkers for mood disorders, specifically focusing on unipolar depression.
-
![GettyImages-1693748594 phone]( "Remote Patient Monitoring Using Mobile Health Technology")
This study investigates the attitudes of cancer patients towards the adoption of mHealth technologies, including applications and wearable devices, for monitoring purposes during or after their treatment.
CONTACT INFORMATION
CHDR
Zernikedreef 8
Leiden, 2333 CL
NETHERLANDS
Phone: +31 715246430
Contact: Wouter ten Voorde
CHDR SOLUTIONS
-
![GettyImages-1391303942 patient doctor HCP]( "Clinical Pharmacokinetics And Pharmacometrics")
Learn about a sophisticated suite of pharmacokinetic (PK) and pharmacometric services designed to accelerate and optimize early-phase drug development.
-
![EU Regulations, europe union flag-GettyImages-1175944437]( "Clinical Trial Regulations")
This essential guide walks through mastering the complex landscape of clinical trial regulations, providing a clear, practical breakdown of regulatory timelines, legal obligations, and more.
-
![GettyImages-1325251634-doctor-patient-blood-pressure-visit]( "Recruitment Strategies: A Behind The Scenes Look")
Explore a dynamic recruitment strategy being used to address the growing demand for participants in early-stage clinical trials while overcoming regulatory and ethical challenges.
-
![iStock-1152216276-skin-dermatology]( "Dermatological Assessments")
Our dermatology studies provide results that are more than skin deep. Because the skin is the largest and most easily accessible organ, our dermatology research also facilitates drug development in other areas, including immunology and endocrinology. In addition, we are engaged in studying ways to improve wound healing.
-
![Human Brain cerebellum-GettyImages-2150929983]( "Gain Objective Measures And Subjective Measures Of CNS Function")
NeuroCart is a fully self-contained, mobile CNS test battery developed in-house at CHDR, offering the possibility to measure a wide range of CNS effects in a pharmacological context.
-
![CHDR neuro feature]( "Measuring A Wide Range Of CNS Effects In A Pharmacological Context")
With nearly three decades of successful application, NeuroCart remains a gold standard in CNS pharmacology, supporting precise, data-driven decisions in drug development.
-
![cell phone data iStock-1274394138]( "Enable Value-Based Evaluation Of Medicines")
Trial@home, CHDR’s dedicated strategy for off-site clinical trials, enables investigators to collect information as trial participants go about their day to day activities.
